Fluticasone Propionate Aerosol, Metered
Product Images NDC 66993-078

Product Visual Gallery

This gallery contains 17 technical images submitted to the FDA as part of the official labeling for Fluticasone Propionate (NDC 66993-078). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Prasco Laboratories, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Fluticasone Propionate Chemical Structure (Fluticasonepropionatehfa Spl Graphic 01)

Chemical structure of fluticasone propionate, the active ingredient in Fluticasone Propionate HFA aerosol inhalation products by Prasco Laboratories.*

FDA Label Image

Figure 1. A 12-week Clinical Trial In Subjects Aged 12 Years And Older Inadequately Controlled On Bronchodilators Alone: Mean Percent Change From Baseline In Fev1 Prior To Am Dose (trial 1) (Fluticasonepropionatehfa Spl Graphic 02)

A line graph comparing percentage change from baseline in FEV1 over a 12-week period for two groups: Placebo and Fluticasone Propionate HFA 88 mcg twice daily. The graph shows FEV1 improvement on the y-axis and weeks on the x-axis. The Fluticasone group shows a higher increase in FEV1 compared to placebo over time.*

FDA Label Image

Figure 2. A 12-week Clinical Trial In Subjects Aged 12 Years And Older Already Receiving Daily Inhaled Corticosteroids: Mean Percent Change From Baseline In Fev1 Prior To Am Dose (trial 2) (Fluticasonepropionatehfa Spl Graphic 03)

A line graph showing the percent change from baseline in FEV1 over a 12-week period for different treatment groups: placebo, Fluticasone Propionate HFA 88 mcg twice daily, 220 mcg twice daily, and 440 mcg twice daily. The x-axis represents weeks, and the y-axis represents percent change from baseline in FEV1. The data illustrate trends in lung function improvement associated with each treatment dose over time.*

FDA Label Image

Figure 3. A 16-week Clinical Trial In Subjects Aged 12 Years And Older Requiring Chronic Oral Prednisone Therapy: Change In Maintenance Prednisone Dose (Fluticasonepropionatehfa Spl Graphic 04)

Bar chart depicting the percentage of subjects achieving 100% reduction in dose and those with an increase in dose. Categories include placebo and two doses of Fluticasone Propionate HFA (440 mcg twice daily and 880 mcg twice daily). The chart compares the effects between these groups.*

FDA Label Image

Figure A (Fluticasonepropionatehfa Spl Graphic 05)

Illustration showing parts of a metered aerosol inhaler including a metal canister, dark orange plastic actuator, dark orange mouthpiece, a dose counter marked '124', and a removable peach-colored cap.*

FDA Label Image

Figure B (Fluticasonepropionatehfa Spl Graphic 06)

An instructional diagram depicting two hands; one hand holds a Fluticasone Propionate HFA metered aerosol inhaler and the other hand is removing a protective cap from the inhaler mouthpiece, indicated by a left-pointing arrow.*

FDA Label Image

Figure C (Fluticasonepropionatehfa Spl Graphic 07)

An instructional illustration showing a person using a metered-dose inhaler labeled Fluticasone Propionate HFA. The image depicts a hand pressing down the spray canister to release aerosol medication toward the mouth for respiratory inhalation, emphasizing the proper spray direction.*

FDA Label Image

Figure D (Fluticasonepropionatehfa Spl Graphic 08)

An instructional illustration showing a hand holding a Fluticasone Propionate HFA metered-dose inhaler, demonstrating how to position the device for use.*

FDA Label Image

Figure E (Fluticasonepropionatehfa Spl Graphic 09)

An instructional illustration showing how to hold an aerosol inhaler in the mouthpiece-down position. The hand grips the inhaler with the dark orange mouthpiece pointed down, and a separate peach-colored protective cap is shown beside it.*

FDA Label Image

Figure F (Fluticasonepropionatehfa Spl Graphic 10)

Illustration showing a side profile of a person exhaling with the instruction 'Breathe out as much air as you can,' indicating a step in the proper use of a respiratory inhalation aerosol device.*

FDA Label Image

Figure G (Fluticasonepropionatehfa Spl Graphic 11)

Instructional illustration showing a person using an inhaler by holding the device near the mouth and pressing down to release the medication while breathing in, demonstrating the correct inhalation technique for a metered-dose aerosol inhaler.*

FDA Label Image

Figure H (Fluticasonepropionatehfa Spl Graphic 12)

An instructional illustration showing a person rinsing their mouth with water, with a glass of water and a faucet visible, likely demonstrating a step for oral hygiene or inhaler use after medication administration.*

FDA Label Image

Figure I (Fluticasonepropionatehfa Spl Graphic 13)

An instructional illustration showing the proper use of the Fluticasone Propionate HFA aerosol inhaler. The top image depicts correct usage with the aerosol spray unobstructed and labeled 'Not blocked.' The bottom image shows improper use with the spray blocked, labeled 'Blocked,' indicating the inhaler mouthpiece should not be obstructed during use.*

FDA Label Image

Figure J (Fluticasonepropionatehfa Spl Graphic 14)

An instructional illustration showing a hand pressing and turning the top of an inhaler device, demonstrating how to use or prepare the aerosol inhaler for administration.*

FDA Label Image

Fluticasone Propionate Hfa 44 Mcg 120 Dose Carton (Fluticasonepropionatehfa Spl Graphic 15)

Label for Fluticasone Propionate HFA Inhalation Aerosol 44 mcg by Prasco Laboratories. The label specifies it is for oral inhalation with Fluticasone Propionate HFA actuator only. It also states each canister contains a suspension of micronized fluticasone propionate in propellant HFA-134a and delivers 44 mcg per actuation, with 120 metered actuations per canister.*

FDA Label Image

Fluticasone Propionate 110 Mcg 120 Dose Carton (Fluticasonepropionatehfa Spl Graphic 16)

Label for Fluticasone Propionate HFA Inhalation Aerosol 110 mcg metered dose by Prasco Laboratories. The label indicates the product is an oral inhalation aerosol with 120 metered actuations per canister, net weight 12 g. It specifies usage with a Fluticasone Propionate HFA actuator only and notes that each actuation delivers 125 mcg from the valve, 110 mcg from the actuator.*

FDA Label Image

Fluticasone Propionate Hfa 220 Mcg Dose Carton (Fluticasonepropionatehfa Spl Graphic 17)

Label for Fluticasone Propionate HFA Inhalation Aerosol 220 mcg by Prasco Laboratories. The label indicates it is an oral inhalation aerosol with 120 metered actuations per canister and a net weight of 12 g. It specifies use only with the Fluticasone Propionate HFA actuator and provides content details about the microcrystalline suspension and propellant.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.